This fact implies that, in spite of its secondary role, the activity of BChE in the bladder could be sufficient to compensate for partial AChE inhibition, when C547 is used at the doses effective in alleviation of MG symptoms. This evidence concerns the gene BCHE and myasthenia gravis.